chrisvoncsefalvay/vaers-outcomes huggingface dataset:
17 y.o. female here to visit University with minimal past medical history who presented to the emergency department for evaluation of hip, neck, elbow, and knee pain that started 7 days prior to admission.  She had been experiencing muscle pain in hips, neck, and knees.  She had diarrhea 1 week prior to her trip on 12/23/2021. Patient also reported nausea and a loss of appetite, but denied dysuria, abnormal vaginal bleeding, vaginal discharge, rashes. Patient also denied being around people who are sick. Denied alcohol use, illicit drug use.  She is vaccinated for COVID-19, and recently received her booster of Pfizer approximately 7 days prior to admission.  She and her mother notes symptoms started approximately 1 day after her vaccine.  She denied any history of nicotine use, drug use, alcohol use, sexual activity.  She has had a few rapid COVID tests over the last few days that are been negative. While in the hospital, she reported migratory joint pain, sore throat, hemoptysis and bilateral subconjunctival hemorrhage: Patient had covid booster on Jan 11, and later started having neck stiffness and headache, followed by migratory joint pain (L knee -> hips -> R knee -> L elbow -> L knee) and fever and chills on Jan 16th. Hemoptysis 1 episode (1/20). Nasal bleed 2 episodes (1/21). All the positive results including C.diff, E.coli, Shigella and Salmonella may explain fever, headache and diarrhea but none of them could explain her symptoms of migratory polyarthritis, hemoptysis, nasal bleeding and subconjunctival hemorrhage.
A physician reported that a 9 month old male received his second doses of Prevnar and Engerix B vaccines on 10/22/02. Concomitant therapy included Amoxicillin. Approximately 24 hours post vaccination, the infant developed vomiting and retching. This child also developed vomiting and retching following receipt of a previous dose of Prevnar. See HQ4818225OCT2002. Information regarding this event has been forwarded to manufacturer of Engerix B.
Child vaccinated app. 10:30am on 11-12-09. Returned to vaccination area at 11:00am complaining of lightheadedness. No other signs or symptoms. In no apparent distress. Child reported he had only cereal for breakfast. RN gave patient apple juice. Monitored patient until mother arrived at 11:33 am. Child A & D, no complaints, INAD.
June 2, 2021 found unconscious in home. Has lost 30+ pounds. Is in and out of conscience mental state since that date. Has been hospitalized 4 weeks since then. Is unable to maintain her own home or drive any longer. Is declining both mentally and physically on a daily basis.  Neurologist is researching a Prion disease, which would be caused by the covid vaccine. More testing to come, but these diseases are verified post-mortem. This is devastating to her and our family.
Information has been received from a nurse referring to multiple unspecified patients. The patients' concurrent condition, medical history and concomitant therapy were not provided. On 17-OCT-2016 and 01-NOV-2016, multiple patients were vaccinated with improperly stored PNEUMOVAX 23 (lot # M000592, expiration date: 12-OCT-2017, lot # reported as M007307 and was invalid lot number for PNEUMOVAX 23, expiration date: 30-OCT-2017) (dose and route not provided). The nurse reported no adverse effects noted. The temperature for the vaccine stored was 10.1 celsius degree with 2 hours time frame. There was no previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.
A total of eight pts had local reactions following vax; 1 of the 8 pts vaxed 21MAY92 & exp restricted arm movement w/moderate pain; 22MAY pain still persisting; treated w/Decadron & inject of Kenalog;
Pt given 12 mo immunizations 5-29-2013. Pt given MMR, VZV, PREVNAR. Pt woke up around midnight and mom stated he was "wheezing and gasping for air". Mom called nurse help-line and then went to near by ER. Pt was seen, examined and released.
patient was administered a dose of the diluent portion of Menveo, without mixing with the lyophilized component; patient was administered a dose of the diluent portion of Menveo, without mixing with the lyophilized component; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA771A, expiry date 31-JAN-2024) for prophylaxis.   On 19-MAY-2023, the patient received Menveo. On 19-MAY-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: patient was administered a dose of the diluent portion of Menveo, without mixing with the lyophilized component) and inappropriate dose of vaccine administered (Verbatim: patient was administered a dose of the diluent portion of Menveo, without mixing with the lyophilized component). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 19-MAY-2023 At the time of reporting, the dose had not been repeated. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. The patient received a dose of the diluent portion of Menveo, without mixing with the lyophilized component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Shakiness-Mild, Systemic: Weakness-Medium, Additional Details: temperature was 99 then 97, BP 88/136, pt laid down and symptoms getting better after 10 minutes but getting worse when 911 arrived. she was concious and no swelling, no energy. She had lighter symptoms from the first dose and contacted her doctor who still recommended second dose after over-reactions.
Symptoms much like brachial neuritis occurred the day following the flu shot. Symptoms continued for about 7 months requiring medication that may have led to other uncomfortable side effects as well.
A report has been received from a Physician concerning a patient, Male subject, who has been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced Granuloma annulare of dorsal hands and elbows. The outcome of the event of Granuloma annulare of dorsal hands and elbows is unknown. The report was considered to be non-serious.
Pt had onset of rash symptoms after receiving vaccine. Appeared as light pink tiny dots, then filled in more completely as red, slightly raised. Initially on trunk, arms and legs. Did present on face (day#2). Administered BENADRYL otc x3. Cleared slowly as of 9/27/09. No fever. No itching noted. Rash was noted 5-10 min after, increased by p.m.  More significant next day.
cough,chills,muscle aches,nasal congestion,fever,headache,vomitting
Ongoing, worsening pain in L arm for 4 weeks after injection. Pain radiates to wrist and to scapula. Causing patient to miss work. Has tried ice, heat, ibuprofen, hydrocodone, and lidocaine patches with limited benefit. Imaging work-up and physical therapy eval pending.
Patient had received single dose of Johnson & Johnson on 3/23/21. When asked if patient had ever received Covid-19 shot previously, patient stated "no". Patient also marked "no" on the first question of the consent form that asks "Have you ever received a Covid-19 vaccine? If so, which one?"
full body hives; treatment of prednisone, benadryl, and pepcid; mostly recovered as of 9/22/2021
Vaccines given 8/24/09 - red swollen, area developed on upper right arm the next day.
This spontaneous report as received from a consumer refers to her 15 years old son who in April 2011, was vaccinated with the first dose of GARDASIL (dose, route and lot number not reported) and he did not get his second dose of GARDASIL and it had been more than a year. This is one of several reports from the same source. Additional information has been requested.
The patient developed a choking/coughing episode resulting in him becoming unresponsive. Patient's wife started CPR, paramedics were called, patient had pulse, but subsequently had seizure activity; patient was intubated and brought to ER by helicopter; eye surgery pending for "burst vessels"; patient lost to followup
Vaccine given after the adjusted use-by date but before the official expiration date. There was no adverse event per, local health dept instructed us to file this report anyway.
patient called in stating she tested positive for covid19 (10/13/21), at an off site location. 2 weeks ago, patient had booster shot, next day started with headache, and cold symptoms, 9/30/21, tested for covid (negative), then turned into "pretty good cold", headache, cough, and lost taste and smell.
I felt extremely dizzy right after getting the shot. I have a history of dizziness associated with an acoustic neuroma that I have, but was not dizzy at all before getting the shot. I was asked to sit for a half hour before leaving. The dizziness subsided in about 15-20 minutes. No other side effect other than sore arm.
4cm area of induration, erythema, warmth, and tenderness at the injection site, most likely allergic reaction related to latex allergy, and the vaccine vial having a latex cap.
A repot was received from a health care professional on 3OCT2003 concerning a 34 year old male vaccinee who inadvertently received expired Fluvirin vaccine on 3OCT2003. On 3OCT2003, the vaccine inadvertently received 2002 Fluvirin vaccine. No adverse effect was reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 2January 2004: Further information was received from a health care professional on 2JAN2004 indicating the vaccinee experienced no adverse reaction. No follow up pending, all information received. Cross reference PJP200300762.
2 x 3" painful rash on inside Left arm. Injection site was (R) arm.
I started getting sick. I went to urgent care and they said I had pneumonia. I was prescribed a z-pack. I called my primary doctor and he prescribed me another z-pack. the following Monday I got worse.
Redness and itching around neck; Redness and itching around neck; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 75 year-old patient received bnt162b2 (BNT162B2), administration date 11Oct2021 (Batch/Lot number: unknown) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), for COVID-19 immunization; Bnt162b2 (Second dose), for COVID-19 immunization. The following information was reported: PRURITUS (non-serious), ERYTHEMA (non-serious) all with onset Oct2021, outcome "unknown" and all described as "Redness and itching around neck".  Follow-up attempts completed. No further information is expected.
Pharmacist  incorrectly drew up 1ml and administered 1mL instead of 0.5mL which is the indicated dose for this vaccine.   Patient within the first 3 hours.
I started having a sore throat and slight cough that morning. In the evening I started getting chills. The next morning on that Tuesday that chills were gone but I was coughing badly with lots of phlegm. I took a COVID-19 test and it was positive. I got PAXLOVID with 3 pills and took it for 5 days. I got better every day. The chills that evening was the worst symptom but everything got better each day. I had a nagging cough for 2 weeks but that also got better every day.
24 hours after the vaccination the patient developed a delayed allergic reaction in the vaccination site (right upper arm). He developed 3 serous filled bulla with the largest measuring  5cm by 2.5cm with surrounding erythema and tenderness to palpation in the area.  This was associated with headache, diaphoresis, shortness of breath, substernal chest discomfort, and sensation of throat itching. By 72 hours the bulla had popped and the patient's the only remaining symptom was right upper arm pain.
Vaccine was exposed to 80.6 degree Fahrenheit for 14 hours 15 minutes/ no AE; Initial information was received on 28-Jul-2021 regarding an unsolicited valid non-serious case received from an Other health professional via Medical Information (Reference number- 00700812) and transmitted to Sanofi on 28-Jul-2021.  This case involves a 16-year-old female patient reported that MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] was exposed to 80.6-degree Fahrenheit for 14 hours 15 minutes with no adverse event (Product storage error) and the patient administered the vaccine after the temperature excursion with no adverse event (Poor quality product administered).  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On 19-Jul-2021, the patient received a 0.5 ml (once) dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [lot U6877BA and expiry date 28-Feb-2022] via intramuscular route in left deltoid for prophylactic vaccination.  It was a case of actual medication error due to incorrect product storage and poor-quality vaccine administered (latency was on same day).  It was reported that, " MA calling to report a temperature excursion caused by a fridge malfunction that lasted for 14 hours 15 minutes with a high temperature of 80.6°F. Medical Assistant reporting on behalf of a 16-year-old female receiving a Menactra dose after the Menactra was exposed to a temperature excursion that made the vaccine not suitable for use. The caller reported that the temperature excursion was on 25Jun2021 and the vaccine was administered on 19Jul2021 and she wants to know if anything needs to be done in regard to this. Vaccines. Product used: Used. Still using product: No".  At the time of reporting, patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
About ten hours after taking the vaccine the nerves in my legs started jumping and quivering and my heart started beating too fast and I couldn't relax. And the next morning I had a cramp in my leg that was the worst cramp I've ever had. There were stabbing pains in my body all through the day and I felt nervous.
8days p/vax pt rpt rash on abd spreading to arms; starting to blister. dx from MD pt w/varicella
much worse; 4 days - higher fever; bad headache; body aches; lymph node swollen for 60 days; Get so very sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07May2021 16:00 (Lot number: ER8731) at the age of 64 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "no health issues other than extreme sensitivity to medications" (unspecified if ongoing); "migraines" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (dose number=1, administration time: 04:00 pm, brand=Pfizer, dose lot number=EW0161, dose vaccine location=Left arm), administration date: 16Apr2021, when the patient was 64 years old, for COVID-19 immunization, reaction(s): "very sick for 3 days", "fever", "headache", "body aches", "lymph node soreness", "Get so very sick". The following information was reported: CONDITION AGGRAVATED (non-serious) with onset 2021, outcome "not recovered", described as "much worse"; PYREXIA (non-serious) with onset 2021, outcome "not recovered", described as "4 days - higher fever"; HEADACHE (non-serious) with onset 2021, outcome "not recovered", described as "bad headache"; PAIN (non-serious) with onset 2021, outcome "not recovered", described as "body aches"; LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovered", described as "lymph node swollen for 60 days"; ILLNESS (non-serious) with onset 2021, outcome "unknown", described as "Get so very sick". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient stated got so very sick with each one, but the Booster has been so bad that I feel I'm dying, literally, and the side effects of high fever, horrendous migraines, horrible body aches go on for many days and weeks. My lymph nodes are swollen for about 2 months. Patient did not receive any other vaccines with in 4 weeks prior to vaccination. Patient did not receive any other medications with in 2 weeks of the vaccination. Prior to vaccination patient did not diagnosed with Covid-19. Patient did not test for Covid-19 since the vaccination.   No follow-up attempts are possible. No further information is expected.
Patient began coughing immediately after sitting down for her observation. Patient had a dry cough. Vitals every 5 minutes. No acute distress, lungs were clear.
I got my sec9nd shot yesterday. I was able to move it fine until.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (I got my sec9nd shot yesterday. I was able to move it fine until.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jun-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (I got my sec9nd shot yesterday. I was able to move it fine until.). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (I got my sec9nd shot yesterday. I was able to move it fine until.) outcome was unknown.            No concomitant medications were reported. No treatment information was provided.
Symptoms were missing heart beats while exercising. Diagnosed with type 2, second degree AV Block, requiring pacemaker.
This spontaneous report was received from other health professional (licensed practical nurse) and refers to a unspecified multiple patients of unknown demographics. There was no information on patient's medical history, concurrent condition, concomitant medication and drug allergies/reactions. On an unknown date, unspecified multiple patients were vaccinated with improperly stored VAQTA (dose, frequency, lot#, expiration date and indication not provided). No adverse effects were reported. The vaccine was stored at temperature of 0.3 degree Celsius for 6 hours. Data logger was involved. There was no previous temperature excursions. No additional information provided. No product quality complaint was involved. No further information provided. This case has been linked with the 1709USA000855, 1709USA004997 and 1709USA004999 as same reporter link. Sender's Comments: US-009507513-1709USA000855: US-009507513-1709USA004997: US-009507513-1709USA004999.
All over body rashes; Shortness of breath; Dizzy; Foggy head; Nausea; Tired/ Fatigue; horrible excruciating migratory arthritic pain; Have variety of symptoms very painful; Areas of my body have been in serious pain; I couldn't walk for days and it affected my right foot and right hip; Really been destroying my health; This is a spontaneous report from a contactable consumer (patient). A 51-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at age of 51-years, and administered in left arm on 02Apr2021 (Lot Number: EL1283) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient was completely heathy before this vaccine. There were no concomitant medications. Historical Vaccine included the first dose of BNT162B2 on an unknown date for covid-19 immunisation. The patient stated that she was having really horrible excruciating migratory arthritic pain and all over body rashes on 07Apr2021 since she took the Pfizer vaccine. it was reported that she had went emergency twice and she had been to the doctors going back to the doctors again and she was going to ask him can she see rheumatologist, they're taking blood test and urine test and she had variety of symptoms very painful. Areas of her body have been in serious pain like it felt like a migratory arthritis kind of pain that just moved area to area every three to four days and twice it got her unable to walk. The patient couldn't walk for days and it affected her right foot and right hip and she was unable to walk since in two instances she was left unable to walk for a few days and it was very painful but she also had like all over body rash, shortness of breath from time to time, dizzy, foggy head, nausea, tired, fatigue. The patient was completely heathy before this vaccine. It had really been destroying her health basically. The patient had been taking pain pills and Benadryl(Treatment) because of the rash and stuff, pain pills for pain but it had not really helping a lot it was just she had been taking like generic Tylenol(Further not clarified). And patient stated above symptoms still happening. The patient underwent lab tests and procedures which included blood test and urine test: normal on Apr2021 (They couldn't find anything wrong with patient).    No follow-up attempts needed. No further information expected.
Large bubble in syringe - she doesn't think she got the full dose; Slight pain in arm; A spontaneous report was received from a consumer (United States) concerning a 74-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced slight pain in arm/pain in extremity after the vaccine and didn't get the full dose/ under dose.   The patient's medical history was unknown. Concomitant product use was unknown.   On 26 Jan 2021, the patient received their first of two planned doses of mrna-1273, batch number not provided intramuscularly in an unknown site for prophylaxis of COVID-19 infection.  On 26th Jan 2021, the patient had received Moderna vaccine. She was given a syringe with vaccine and told to have a seat. Patient realized that there was a large bubble inside the syringe.  After receiving the dose patient has a slight pain in her arm and she felt that she didn't receive the whole dose.  .   Treatment information was unknown.  Action taken with mrna-1273 in response to the event was unknown.  The outcome of the event, slight pain in the arm was unknown. The outcome of the event, didn't get full dose was resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  The causality for the event of underdose is assessed as not applicable.